Diagnostics and therapy of acute myeloid leukemia

被引:1
作者
Bornhaeuser, M. [1 ]
Ehninger, G. [1 ]
机构
[1] Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, D-01307 Dresden, Germany
关键词
acute myeloid leukemia; risk-adapted therapy; STEM-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; TOTAL-BODY; MUTATIONS; SURVIVAL; CLASSIFICATION; IRRADIATION; RELAPSE;
D O I
10.1055/s-0029-1237534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1935 / 1941
页数:7
相关论文
共 16 条
[1]   Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation [J].
Bacher, Ulrike ;
Badbaran, Anita ;
Fehse, Boris ;
Zabelina, Tatjana ;
Zander, Axel Rolf ;
Kroeger, Nicolaus .
EXPERIMENTAL HEMATOLOGY, 2009, 37 (01) :135-142
[2]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[3]  
Büchner T, 1999, BLOOD, V93, P4116
[4]   Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? [J].
Cornelissen, Jan J. ;
van Putten, Wim L. J. ;
Verdonck, Leo F. ;
Theobald, Matthias ;
Jacky, Emanuel ;
Daenen, Simon M. G. ;
Kooy, Marinus van Marwijk ;
Wijermans, Pierre ;
Schouten, Harry ;
Huijgens, Peter C. ;
van der Lelie, Hans ;
Fey, Martin ;
Ferrant, Augustin ;
Maertens, Johan ;
Gratwohl, Alois ;
Lowenberg, Bob .
BLOOD, 2007, 109 (09) :3658-3666
[5]   Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].
Cornely, Oliver A. ;
Maertens, Johan ;
Winston, Drew J. ;
Perfect, John ;
Ullmann, Andrew J. ;
Walsh, Thomas J. ;
Helfgott, David ;
Holowiecki, Jerzy ;
Stockelberg, Dick ;
Goh, Yeow-Tee ;
Petrini, Mario ;
Hardalo, Cathy ;
Suresh, Ramachandran ;
Angulo-Gonzalez, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359
[6]   Flow cytometric immunophenotyping for hematologic neoplasms [J].
Craig, Fiona E. ;
Foon, Kenneth A. .
BLOOD, 2008, 111 (08) :3941-3967
[7]   Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors [J].
Hegenbart, U ;
Niederwieser, D ;
Sandmaier, BM ;
Maris, MB ;
Shizuru, JA ;
Greinix, H ;
Cordonnier, C ;
Rio, B ;
Gratwohl, A ;
Lange, T ;
Al-Ali, H ;
Storer, B ;
Maloney, D ;
McSweeney, P ;
Chauncey, T ;
Agura, E ;
Bruno, B ;
Maziarz, RT ;
Petersen, F ;
Storb, R .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :444-453
[8]   Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia:: Results from cancer and leukemia group B study 8461 [J].
Marcucci, G ;
Mrózek, K ;
Ruppert, AS ;
Archer, KJ ;
Pettenati, MJ ;
Heerema, NA ;
Carroll, AJ ;
Koduru, PRK ;
Kolitz, JE ;
Sterling, LJ ;
Edwards, CG ;
Anastasi, J ;
Larson, RA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2410-2418
[9]   Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia [J].
Platzbecker, U ;
Thiede, C ;
Fuessel, M ;
Geissler, G ;
Illmer, T ;
Mohr, B ;
Hänel, M ;
Mahlberg, R ;
Krümpelmann, U ;
Weissinger, F ;
Schaich, M ;
Theuser, C ;
Ehninger, G ;
Bornhäuser, M .
LEUKEMIA, 2006, 20 (04) :707-714
[10]   Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients [J].
SanMiguel, JF ;
Martinez, A ;
Macedo, A ;
Vidriales, MB ;
LopezBerges, C ;
Gonzalez, M ;
Cabaliero, D ;
GarciaMarcos, MA ;
Ramos, F ;
FernandezCalvo, J ;
Calmuntia, MJ ;
DiazMediavilla, J ;
Orfao, A .
BLOOD, 1997, 90 (06) :2465-2470